Thursday, April 28, 2022 9:00 AM to 4:00 PM
Wilentz Health, Cannabis, and Corporate law Co-Chair, Past Co-Chair of the NJSBA Cannabis Law Committee and Past Chair of the Health Law Section, and current NJSBA Trustee, Michael F. Schaff, will moderate the NJICLE’s 4th Annual Cannabis Symposium, which will address the latest developments on federal, state, and local cannabis laws and regulations. Wilentz Shareholder, current NJSBA Health Law Section Chair, and NJSBA Cannabis Law Committee Co-Chair, Lisa Gora, will present “2019 RFA Awardee Update,” and Shareholder and Employment, and Cannabis law attorney Tracy Armstrong will present as part of the “Labor and Employment Cannabis Update.”
This year’s symposium will feature a presentation by the NJ Cannabis Regulatory Commission’s Chairwoman Dianna Houenou and Chief Counsel Christopher Riggs, and a presentation by Senator Vin Gopal.
The program agenda includes:
- Cannabis and Capital Markets
- Hemp, Seed to Sale
- Insights from a Multistate Operator
- The Social Equity Remedy: Cannabis
- New York Cannabis Law Update
- Renewed 2018 Litigation
- Employment Law Guidance
This program has been approved by the Board on Continuing Legal Education of the Supreme Court of New Jersey for 6.7 hours of total CLE credit, out of which 1.0 qualify as hours of credit for diversity and inclusion.
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.